Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Immunohistochemistry Market Led by Diagnostics Segment with 60%+ Share; Market Projected to Reach USD 4.42 billion by 2031, Mordor Intelligence Reports

globenewswire.com
GEHC GE Healthcare is mentioned as a major company in the respiratory monitoring market, which is projected to grow. The article does not provide specific sentiment towards GE Healthcare itself. MDT Medtronic plc is listed as a major company in the respiratory monitoring market, which is expected to grow. The article does not offer specific sentiment for Medtronic. MASI Masimo Corporation is identified as a major player in the respiratory monitoring market, which is projected for growth. No specific sentiment is expressed towards Masimo. ABT Abbott is mentioned as a major company in the sepsis diagnostics market, which is projected to grow. The article does not provide specific sentiment for Abbott. BDX Becton, Dickinson, and Company is listed as a major company in the sepsis diagnostics market, which is expected to grow. The article does not offer specific sentiment for BDX.

Immunohistochemistry Market Led by Diagnostics Segment with 60%+ Share; Market Projected to Reach USD 4.42 billion by 2031, Mordor Intelligence Reports Hyderabad, India, April 10, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the immunohistochemistry market size was valued at USD 2.98 billion in 2025 and is projected to grow from USD 3.18 billion in 2026 to USD 4.42 billion by 2031, registering a CAGR of 6.78% during the forecast period (2026–2031). The market growth is driven by the increasing demand for accurate and early disease diagnosis, particularly in oncology. The expansion of personalized medicine and targeted therapies is significantly contributing to the adoption of immunohistochemistry techniques, as they play a crucial role in identifying specific biomarkers and guiding treatment decisions. Healthcare systems worldwide are focusing on improving diagnostic capabilities, thereby reinforcing the demand for advanced immunohistochemistry solutions.

The growing burden of cancer and other chronic diseases is accelerating the use of immunohistochemistry in clinical diagnostics and research applications. Rising awareness about early detection and the importance of precise diagnosis is further strengthening market growth. Additionally, the integration of automation and digital pathology technologies is enhancing laboratory efficiency, improving workflow, and reducing turnaround times. Technological advancements continue to shape the immunohistochemistry market, with the development of highly specific antibodies, advanced staining systems, and multiplex assays enabling more reliable and comprehensive analysis. Increasing investments in research and development, along with collaborations between diagnostic companies and research institutions, are supporting innovation and expanding application areas.

Soumya Goud, Senior Research Manager, Mordor Intelligence says, “Our assessment reflects consistent demand patterns across diagnostics and research use, supported by verifiable industry data and cross-validated sources. The study’s structured methodology and transparent assumptions provide decision-makers with a dependable, comparable view relative to other available analyses.”

Immunohistochemistry Market Share by Region

Immunohistochemistry Market Trends & Forecast

Growing Adoption of Companion Diagnostics

The increasing use of targeted therapies is driving demand for immunohistochemistry to identify disease-specific biomarkers and support treatment decisions.

Advancements in Automation and Digital Pathology

The integration of automated systems and digital pathology is enhancing diagnostic accuracy, efficiency, and scalability in laboratory settings.

Immunohistochemistry Market Segmentation Overview

By Product

By Application

By End-User

By Detection Method

By Geography

For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/immunohistochemistry-market?utm_source=globenewswire

Immunohistochemistry Market Competitive Outlook

The immunohistochemistry market features global diagnostics and biotechnology companies focusing on innovation, automation, and expansion of product portfolios. Market players are investing in advanced antibody development, digital pathology integration, and strategic collaborations to strengthen their market presence and meet the growing demand for diagnostic solutions.

Major Companies in Immunohistochemistry include:

Check out related reports published by Mordor Intelligence:

Body Composition Analyzers Market Size

The body composition analyzers market is estimated at USD 674.92 million in 2026 and is projected to reach USD 887.36 million by 2031, registering a CAGR of 5.62% during the forecast period. Growth is driven by increasing health awareness, rising demand for fitness monitoring solutions, and expanding adoption in clinical and wellness settings.

Respiratory Monitoring Market Share

The respiratory monitoring market is estimated to grow from USD 13.36 billion in 2026 to USD 22.59 billion by 2031, registering a CAGR of 11.08% during the forecast period. Market expansion is supported by the rising prevalence of respiratory diseases, increasing demand for remote patient monitoring, and growing adoption of advanced monitoring technologies.

Koninklijke Philips N.V., Medtronic plc, GE Healthcare, Masimo Corporation and Vyaire Medical Inc. are the major companies operating in this market.

Read more about companies in the respiratory monitoring market: https://www.mordorintelligence.com/industry-reports/global-respiratory-monitoring-market-industry/companies?utm_source=globenewswire

Sepsis Diagnostics Market Trends

The sepsis diagnostics market is estimated at USD 0.79 billion in 2025 and is projected to reach USD 1.08 billion by 2030, registering a CAGR of 6.58% during the forecast period. Growth is driven by increasing incidence of sepsis, rising need for early and accurate diagnosis, and growing adoption of advanced molecular diagnostic solutions.

Abbott, Diasorin, Becton, Dickinson, and Company, bioMérieux SA and F. Hoffmann-LA Roche Ltd are the major companies operating in this market.

Read more about companies in the sepsis diagnostics market: https://www.mordorintelligence.com/industry-reports/sepsis-diagnostics-market/companies?utm_source=globenewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.